• OPEN AN ACCOUNT
Indian Indices
Sensex
76,957.27 -307.24
( -0.40%)
Global Indices
Nasdaq
53,227.35 -353.64
(-0.66%)
Dow Jones
7,711.10 -21.66
(-0.28%)
Hang Seng
66,147.06 -258.50
(-0.39%)
Nikkei 225
10,824.26 31.76
(0.29%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

BSE 500 Dividend Leaders 50
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
1208
N.A
0
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
12.05
0
EPS(TTM)
Face Value()
Div & Yield %
0
100
2.69
 

Kilitch Drugs (India) consolidated net profit declines 25.67% in the December 2025 quarter
Feb 12,2026
Net profit of Kilitch Drugs (India) declined 25.67% to Rs 4.43 crore in the quarter ended December 2025 as against Rs 5.96 crore during the previous quarter ended December 2024. Sales declined 4.20% to Rs 53.81 crore in the quarter ended December 2025 as against Rs 56.17 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales53.8156.17 -4
OPM %11.4315.54 -
PBDT6.539.06 -28
PBT5.608.25 -32
NP4.435.96 -26